Exercise Induced Hypoalgesia in Pain-free Stroke and Healthy Populations: a Cohort Study
NCT ID: NCT07327593
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2026-01-31
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Although there has been extensive research on EIH in healthy populations and those with chronic musculoskeletal pain, surprisingly little attention has been given to individuals with neurological pathologies. Chronic pain is found in more than 50% of patients after stroke, and 70% of affected individuals experience pain on daily activities. Reported prevalences of post-stroke pain (PSP) between different studies, but there is a general consensus that it is an underreported phenomenon. Patients with pain experience greater cognitive and functional decline, fatigue, depression and lower quality of life.
Multiple factors contribute to PSP, and various approaches exist to treat all the variables influencing it. This study aims to compare the effects of exercise on pain perception in healthy individuals and stroke patients without pain, using the same cardiovascular training protocol, to better understand the mechanisms of EIH and its maintenance after stroke, ultimately aiming to improve the treatment of people with stroke.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Aerobic Exercise on Pain Modulation in Healthy Adults
NCT07083219
Immediate Exercise-Induced Hypoalgesia in Patients With Chronic Low Back Pain
NCT05077566
Disentangling the Variability of Exercise-induced Hypoalgesia: the Role of Circulatory Compounds
NCT06967714
Effects of Different Kinds of Exercise in Low Back Pain
NCT06330961
Improvement in Pain,Function and HRQoL ( Health Related Quality of Life) in Subacute Low Back Pain: A Controlled Clinical Trial of Exercise vs NSAIDs (Nonsteroidal Antiinflammatory)
NCT01374269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy cohort
Age \> 18 years; no neurological damage; no medical conditions that could affect the test; no pain of duration \> 1 week in the 3 months preceding the enrollment. No serious medical conditions.
First, pressure pain thresholds and conditioned pain modulation will be assessed. Then, participants will conduct a cardiovascular training for 30 minutes, and will be reassessed inmediately post-training and 30 minutes after.
Cardiovascular training
The cardiovascular training protocol will consist of a 5-minute warm-up aimed at reaching 70% of maximum heart rate (MHR) followed by 20 minutes of sustained work at this intensity (since maintaining this intensity is difficult, especially in the stroke cohort, we will allow for a margin of ±2-3% of MHR and provide feedback to increase or decrease the heart rate). We will aim to keep the heart rate below 73% of maximum heart rate, maintain blood pressure within safe ranges, and keep the effort level between 14/20 and 16/20
Post-stroke pain free cohort
Ischemic or hemorrhagic stroke (\> 3 months); older than 18 years old; of duration \> 1 week in the 3 months preceding the enrollment. No other serious medical conditions.
Post-stroke participants will get the same study protocol than healthy cohort.
Cardiovascular training
The cardiovascular training protocol will consist of a 5-minute warm-up aimed at reaching 70% of maximum heart rate (MHR) followed by 20 minutes of sustained work at this intensity (since maintaining this intensity is difficult, especially in the stroke cohort, we will allow for a margin of ±2-3% of MHR and provide feedback to increase or decrease the heart rate). We will aim to keep the heart rate below 73% of maximum heart rate, maintain blood pressure within safe ranges, and keep the effort level between 14/20 and 16/20
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiovascular training
The cardiovascular training protocol will consist of a 5-minute warm-up aimed at reaching 70% of maximum heart rate (MHR) followed by 20 minutes of sustained work at this intensity (since maintaining this intensity is difficult, especially in the stroke cohort, we will allow for a margin of ±2-3% of MHR and provide feedback to increase or decrease the heart rate). We will aim to keep the heart rate below 73% of maximum heart rate, maintain blood pressure within safe ranges, and keep the effort level between 14/20 and 16/20
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Post-stroke cohort: : Ischemic or hemorrhagic stroke (\> 3 months); age \> 18 years; no pain
Exclusion Criteria
* Post-stroke cohort: Unable to participate in the test (no possibility of transfer or active pedaling); medical contraindication to cardiovascular training for any reason; inability to follow instructions or communicate sensations during training; other neurological pathology; cardiac pathology (unstable angina, arrhythmias, aortic or left ventricular problems, myocarditis, pericarditis); pulmonary pathology that affects the test (pulmonary embolisms, pulmonary hypertension, etc.); renal or metabolic problems (severe renal dysfunction, uncontrolled diabetes, etc.); acute infection or fever; neurosurgery within 6 weeks prior to inclusion in the study; pain in any location, lasting \> 1 week in the 3 months prior to the trial.; use of beta-blockers, antidepressants, or any medication that may alter heart rate measurements
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neuron, Spain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alejandro Herrera Rojas, Physical Therapist
Role: PRINCIPAL_INVESTIGATOR
Neuron, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neuron Madrid Río
Madrid, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NeuronRehab
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.